NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

InflaRx N.V (NASDAQ: IFRX)

 
IFRX Technical Analysis
5
As on 8th Aug 2025 IFRX STOCK Price closed @ 0.80 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.69 & Strong Sell for SHORT-TERM with Stoploss of 1.51 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IFRXSTOCK Price

Open 0.82 Change Price %
High 0.86 1 Day -0.02 -2.44
Low 0.78 1 Week -0.08 -9.09
Close 0.80 1 Month -0.03 -3.61
Volume 158942 1 Year -0.71 -47.02
52 Week High 2.70 | 52 Week Low 0.73
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
SGBX 0.40 37.93%
NCNA 0.03 0.00%
NVDA 182.70 1.07%
LMDX 0.02 0.00%
MRM 2.76 130.00%
AAPL 229.35 4.24%
TTD 54.23 -38.61%
AKTS 0.04 0.00%
TSLA 329.65 2.29%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NBSTU 12.99 220.74%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
GLSPT 33.43 138.62%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ZVZZT 21.37 -80.18%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
RELIW 0.03 -66.67%
TFFP 0.06 -62.50%
 
 
IFRX
Daily Charts
IFRX
Intraday Charts
Whats New @
Bazaartrend
IFRX
Free Analysis
 
IFRX Important Levels Intraday
RESISTANCE0.95
RESISTANCE0.90
RESISTANCE0.87
RESISTANCE0.84
SUPPORT0.76
SUPPORT0.73
SUPPORT0.70
SUPPORT0.65
 
IFRX Forecast August 2025
4th UP Forecast1.82
3rd UP Forecast1.49
2nd UP Forecast1.29
1st UP Forecast1.09
1st DOWN Forecast0.51
2nd DOWN Forecast0.31
3rd DOWN Forecast0.11
4th DOWN Forecast-0.22
 
IFRX Weekly Forecast
4th UP Forecast1.47
3rd UP Forecast1.26
2nd UP Forecast1.12
1st UP Forecast0.99
1st DOWN Forecast0.61
2nd DOWN Forecast0.48
3rd DOWN Forecast0.34
4th DOWN Forecast0.13
 
IFRX Forecast2025
4th UP Forecast4.87
3rd UP Forecast3.56
2nd UP Forecast2.76
1st UP Forecast1.95
1st DOWN Forecast-0.35
2nd DOWN Forecast-1.16
3rd DOWN Forecast-1.96
4th DOWN Forecast-3.27
 
 
IFRX Other Details
Segment EQ
Market Capital 180721968.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
IFRX Address
IFRX
 
IFRX Latest News
 
Your Comments and Response on InflaRx N.V
 
IFRX Business Profile
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in the Germany and United States. Its C5a is an inflammatory mediator that is involved in the enhancement of a variety of autoimmune and other inflammatory diseases. The company's lead product candidate is IFX-1, an intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase IIb clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; to treat ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and for the treatment of pyoderma gangrenosum, a chronic inflammatory skin disorder, as well as developing IFX-1 for the treatment of oncological diseases. It also develops IFX-2 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases. InflaRx N.V. has co-development agreement with Beijing Defengrei Biotechnology Co. Ltd. The company was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. InflaRx N.V. was founded in 2007 and is headquartered in Jena, Germany. Address: Winzerlaer Str. 2, Jena, Germany, 07745
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service